Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial.

Dukka H, Kalra PA, Wilkie M, Bhandari S, Davies SJ, Barratt J, Squire I, Odudu A, Selby NM, McIntyre C, Robertson F, Taal MW.

Perit Dial Int. 2019 Sep-Oct;39(5):486-489. doi: 10.3747/pdi.2018.00272.

PMID:
31501293
2.

Applying Improvement Science to Peritoneal Access-Why We Need to Understand What Works and What Does Not.

Wilkie M.

Perit Dial Int. 2019 Sep-Oct;39(5):397-398. doi: 10.3747/pdi.2019.00131. No abstract available.

PMID:
31501289
3.

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization.

Jochems SP, de Ruiter K, Solórzano C, Voskamp A, Mitsi E, Nikolaou E, Carniel BF, Pojar S, German EL, Reiné J, Soares-Schanoski A, Hill H, Robinson R, Hyder-Wright AD, Weight CM, Durrenberger PF, Heyderman RS, Gordon SB, Smits HH, Urban BC, Rylance J, Collins AM, Wilkie MD, Lazarova L, Leong SC, Yazdanbakhsh M, Ferreira DM.

J Clin Invest. 2019 Jul 30;130:4523-4538. doi: 10.1172/JCI128865.

4.

Shared Hemodialysis Care: Increasing Patient Involvement in Center-Based Dialysis.

Wilkie M, Barnes T.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1402-1404. doi: 10.2215/CJN.02050219. Epub 2019 Jul 26. No abstract available.

PMID:
31350275
5.

Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes?

Connell DW, Wilkie M.

Eur Respir J. 2019 Jul 11;54(1). pii: 1901121. doi: 10.1183/13993003.01121-2019. Print 2019 Jul. No abstract available.

PMID:
31296785
6.

Can Lower Dialysate Sodium Concentrations Contribute to Blood Pressure Control in Peritoneal Dialysis?

Wilkie M, Davies S.

Perit Dial Int. 2019 Jul-Aug;39(4):297-298. doi: 10.3747/pdi.2019.00069. No abstract available.

PMID:
31296774
7.

An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.

Manera KE, Tong A, Craig JC, Shen J, Jesudason S, Cho Y, Sautenet B, Teixeira-Pinto A, Howell M, Wang AY, Brown EA, Brunier G, Perl J, Dong J, Wilkie M, Mehrotra R, Pecoits-Filho R, Naicker S, Dunning T, Scholes-Robertson N, Johnson DW.

Kidney Int. 2019 Sep;96(3):699-710. doi: 10.1016/j.kint.2019.03.015. Epub 2019 Mar 29.

PMID:
31200941
8.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
9.

Enabling Supported Self-Care.

Wilkie M.

Perit Dial Int. 2019 May-Jun;39(3):199-200. doi: 10.3747/pdi.2019.00018. No abstract available.

PMID:
31088932
10.

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.

Manjaly Thomas ZR, Satti I, Marshall JL, Harris SA, Lopez Ramon R, Hamidi A, Minhinnick A, Riste M, Stockdale L, Lawrie AM, Vermaak S, Wilkie M, Bettinson H, McShane H.

PLoS Med. 2019 Apr 30;16(4):e1002790. doi: 10.1371/journal.pmed.1002790. eCollection 2019 Apr.

11.

Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update.

Crabtree JH, Shrestha BM, Chow KM, Figueiredo AE, Povlsen JV, Wilkie M, Abdel-Aal A, Cullis B, Goh BL, Briggs VR, Brown EA, Dor FJMF.

Perit Dial Int. 2019 Sep-Oct;39(5):414-436. doi: 10.3747/pdi.2018.00232. Epub 2019 Apr 26. No abstract available.

12.

Fungal diseases at the medical front door.

Wilson A, Wilkie M, Rae N.

Br J Hosp Med (Lond). 2019 Mar 2;80(3):157-161. doi: 10.12968/hmed.2019.80.3.157. Review.

PMID:
30860923
13.

Peritoneal Dialysis for People with Functional Impairment-What About Carer Support?

Wilkie M.

Perit Dial Int. 2019 Mar-Apr;39(2):101-102. doi: 10.3747/pdi.2018.00259. No abstract available.

PMID:
30858283
14.

The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.

Fotheringham J, Sajjad A, Stel VS, McCullough K, Karaboyas A, Wilkie M, Bieber B, Robinson BM, Massy ZA, Jager KJ.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1577-1584. doi: 10.1093/ndt/gfz007.

15.

Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death.

Lambie M, Teece L, Johnson DW, Petrie M, Mactier R, Solis-Trapala I, Belcher J, Bekker HL, Wilkie M, Tupling K, Phillips-Darby L, Davies SJ.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1585-1591. doi: 10.1093/ndt/gfz034.

16.

International Variations in Peritoneal Dialysis Utilization and Implications for Practice.

Briggs V, Davies S, Wilkie M.

Am J Kidney Dis. 2019 Jul;74(1):101-110. doi: 10.1053/j.ajkd.2018.12.033. Epub 2019 Feb 22. Review.

PMID:
30799030
17.

Defining the role of surgical drainage in paediatric deep neck space infections.

Wilkie MD, De S, Krishnan M.

Clin Otolaryngol. 2019 May;44(3):366-371. doi: 10.1111/coa.13315. Epub 2019 Mar 25.

PMID:
30784193
18.

Control of invasive sea lampreys using the piscicides TFM and niclosamide: Toxicology, successes & future prospects.

Wilkie MP, Hubert TD, Boogaard MA, Birceanu O.

Aquat Toxicol. 2019 Jun;211:235-252. doi: 10.1016/j.aquatox.2018.12.012. Epub 2018 Dec 21. Review.

19.

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.

Tanner R, Smith SG, van Meijgaarden KE, Giannoni F, Wilkie M, Gabriele L, Palma C, Dockrell HM, Ottenhoff THM, McShane H.

J Immunol Methods. 2019 Jun;469:1-10. doi: 10.1016/j.jim.2019.01.006. Epub 2019 Jan 31.

20.

Transition-The Process of Changing from One State to Another.

Wilkie M.

Perit Dial Int. 2019 Jan-Feb;39(1):3. doi: 10.3747/pdi.2018.00210. No abstract available.

PMID:
30692231
21.

Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis: Multinational Nominal Group Technique Study.

Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY, Yip T, Fung SKS, Tong M, Lee A, Cho Y, Viecelli AK, Sautenet B, Teixeira-Pinto A, Brown EA, Brunier G, Dong J, Dunning T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wilkie M, Tong A.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):74-83. doi: 10.2215/CJN.05380518. Epub 2018 Dec 20.

PMID:
30573659
22.

Insights on Peritoneal Dialysis in China.

Wilkie M, Davies S.

Perit Dial Int. 2018 Dec;38(Suppl 2):S16-S18. doi: 10.3747/pdi.2018.00224. Review.

PMID:
30530596
23.

Does alanyl-glutamine supplementation offer potential to improve peritoneal dialysate biocompatibility?

Wilkie M, Davies S.

Kidney Int. 2018 Dec;94(6):1050-1052. doi: 10.1016/j.kint.2018.09.012.

PMID:
30466563
24.

Papers from Japan: Catheter Implantation, and the Link Between Frailty and Mortality.

Wilkie M, Fotheringham J.

Perit Dial Int. 2018 Nov-Dec;38(6):395-396. doi: 10.3747/pdi.2018.00161. No abstract available.

PMID:
30413634
25.

Starting Dialysis-Planning for the Unpredictable and the Search for Meaningful Process Measures.

Wilkie M.

Perit Dial Int. 2018 Sep-Oct;38(5):317-318. doi: 10.3747/pdi.2018.00097. No abstract available.

PMID:
30185476
26.

Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.

Wilkie MD, Lau AS, Vlatkovic N, Jones TM, Boyd MT.

Oral Oncol. 2018 Aug;83:1-10. doi: 10.1016/j.oraloncology.2018.05.018. Epub 2018 Jun 2. Review.

PMID:
30098763
27.

Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.

Wilkie MD, Fraser HM, Raja H.

Eur Arch Otorhinolaryngol. 2018 Oct;275(10):2515-2521. doi: 10.1007/s00405-018-5079-0. Epub 2018 Jul 30.

PMID:
30062580
28.
29.

Assessing off-target cytotoxicity of the field lampricide 3-trifluoromethyl-4-nitrophenol using novel lake sturgeon cell lines.

Vo NTK, Moore LC, Spiteri KW, Hanner R, Wilkie MP, DeWitte-Orr SJ.

Ecotoxicol Environ Saf. 2018 Oct 30;162:536-545. doi: 10.1016/j.ecoenv.2018.07.017. Epub 2018 Jul 17.

PMID:
30016760
30.

Chapter 10 Multisite Dialysis Access Audit in England, Northern Ireland and Wales and 2015 Peritoneal.

Hole B, Magadi W, Steenkamp R, Fluck R, Kumwenda M, Wilkie M.

Nephron. 2018;139 Suppl 1:253-272. doi: 10.1159/000490968. Epub 2018 Jul 10. No abstract available.

31.

Stories and Stuff.

Wilkie M.

Perit Dial Int. 2018 Jul-Aug;38(4):238-239. doi: 10.3747/pdi.2018.00057. No abstract available.

PMID:
29987062
32.

Advanced Laparoscopic Peritoneal Dialysis Catheter Insertion: Systematic Review and Meta-Analysis.

Shrestha BM, Shrestha D, Kumar A, Shrestha A, Boyes SA, Wilkie ME.

Perit Dial Int. 2018 May-Jun;38(3):163-171. doi: 10.3747/pdi.2017.00230.

PMID:
29848597
33.

PD First in South Africa and Thailand.

Wilkie M.

Perit Dial Int. 2018 May-Jun;38(3):159-160. doi: 10.3747/pdi.2018.00009. No abstract available.

PMID:
29848595
34.

United Kingdom Catheter Study - Protocol Synopsis.

Briggs V, Solis-Trapala I, Wailloo A, McCulloch K, Lambie M, Caskey F, Fotheringham J, Davies S, Wilkie M.

Perit Dial Int. 2018 Mar-Apr;38(2):113-118. doi: 10.3747/pdi.2017.00083. Erratum in: Perit Dial Int. 2018 Jul-Aug;38(4):314.

PMID:
29563275
35.

Fluid Assessment in Peritoneal Dialysis-There Is Still a Place for Clinical Acumen.

Wilkie M, Davies S.

Perit Dial Int. 2018 Mar-Apr;38(2):81-82. doi: 10.3747/pdi.2017.00248. No abstract available.

PMID:
29563272
36.

Supporting the Health of Low Socioeconomic Status Employees: Qualitative Perspectives From Employees and Large Companies.

Parrish AT, Hammerback K, Hannon PA, Mason C, Wilkie MN, Harris JR.

J Occup Environ Med. 2018 Jul;60(7):577-583. doi: 10.1097/JOM.0000000000001318.

PMID:
29538272
37.

Peritoneal Dialysis (PD) to Support Nonrenal Solid-Organ Transplantation.

Wilkie M.

Perit Dial Int. 2018 Jan-Feb;38(1):3. doi: 10.3747/pdi.2017.00192. No abstract available.

PMID:
29311190
38.

Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis.

Fotheringham J, Barnes T, Dunn L, Lee S, Ariss S, Young T, Walters SJ, Laboi P, Henwood A, Gair R, Wilkie M.

BMC Nephrol. 2017 Nov 24;18(1):335. doi: 10.1186/s12882-017-0748-6.

39.
40.

Overcoming Low Health Literacy to Strengthen Modality Choices Requires Individualized Responses.

Wilkie M.

Perit Dial Int. 2017 Nov-Dec;37(6):589-590. doi: 10.3747/pdi.2017.00142. No abstract available.

PMID:
29122998
41.

UNITED KINGDOM CATHETER STUDY - PROTOCOL SYNOPSIS.

Briggs V, Solis-Trapala I, Wailoo A, McCullough K, Lambie M, Caskey FJ, Fotheringham J, Davies SJ, Wilkie M.

Perit Dial Int. 2017 Sep 28. pii: pdi.2017-00083. doi: 10.3747/pdi.2017-00083. [Epub ahead of print]

PMID:
28970368
42.

Strengthening the Reporting of Cohort Studies in Peritoneal Dialysis.

Wilkie M.

Perit Dial Int. 2017 Sep-Oct;37(5):489-490. doi: 10.3747/pdi.2017.00090. No abstract available.

PMID:
28931692
43.

UK Renal Registry 19th Annual Report: Chapter 13 Home Therapies in 2015: National and Centre-specific Analyses.

Tabinor M, Casula A, Wilkie M, Davies S, Caskey F, Lambie M.

Nephron. 2017;137 Suppl 1:297-326. doi: 10.1159/000481376. Epub 2017 Sep 29. No abstract available.

44.

UK Renal Registry 19th Annual Report: Chapter 12 Multisite Dialysis Access Audit in England, Northern Ireland and Wales in 2015 and 2014 PD One Year Follow-up: National and Centre-specific Analyses.

Hole B, Caskey F, Evans K, Fluck R, Kumwenda M, Steenkamp R, Wilkie M.

Nephron. 2017;137 Suppl 1:269-296. doi: 10.1159/000481374. Epub 2017 Sep 29. No abstract available.

45.

The BeSMART (Best Supportive Management for Adults Referred with Tonsillopharyngitis) multicentre observational study.

Lau AS, Mamais C, McChesney E, Upile NS, Vaughan C, Veitch J, Abbas JR, Markey A, Brown NG, Evans M, Thomas J, Gaines M, Shehata Z, Wilkie MD, Leong SC.

Ann R Coll Surg Engl. 2017 Sep;99(7):573-578. doi: 10.1308/rcsann.2017.0106.

46.

A role for tight junction-associated MARVEL proteins in larval sea lamprey (Petromyzon marinus) osmoregulation.

Kolosov D, Bui P, Donini A, Wilkie MP, Kelly SP.

J Exp Biol. 2017 Oct 15;220(Pt 20):3657-3670. doi: 10.1242/jeb.161562. Epub 2017 Aug 10.

47.

Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): Study Protocol for Establishing a Core Outcome Set in PD.

Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, Dunning T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wang AY, Wilkie M, Howell M, Sautenet B, Evangelidis N, Shen JI, Johnson DW; SONG-PD Investigators.

Perit Dial Int. 2017 Nov-Dec;37(6):639-647. doi: 10.3747/pdi.2017.00022. Epub 2017 Aug 1.

48.

Overcoming Socioeconomic Differences in the Equitable Delivery of Peritoneal Dialysis.

Wilkie M.

Perit Dial Int. 2017 Jul-Aug;37(4):354-355. doi: 10.3747/pdi.2017.00039. No abstract available.

PMID:
28676504
49.

A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.

Zavvos V, Buxton AT, Evans C, Lambie M, Davies SJ, Topley N, Wilkie M, Summers A, Brenchley P, Goumenos DS, Johnson TS.

Kidney Int. 2017 Oct;92(4):988-1002. doi: 10.1016/j.kint.2017.03.030. Epub 2017 Jul 1.

50.

Effects of water pH on the uptake and elimination of the piscicide, 3-trifluoromethyl-4-nitrophenol (TFM), by larval sea lamprey.

Hlina BL, Tessier LR, Wilkie MP.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Oct;200:9-16. doi: 10.1016/j.cbpc.2017.05.005. Epub 2017 Jun 3.

Supplemental Content

Loading ...
Support Center